Akira Matayoshi
Overview
Explore the profile of Akira Matayoshi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miyamoto S, Goto T, Shirakawa J, Kawano T, Murahashi M, Ide K, et al.
Exp Ther Med
. 2023 Feb;
25(3):141.
PMID: 36845954
Odontogenic keratocysts (OKCs) often occur in the molars in the mandibular ramus; they often progress asymptomatically and are discovered only after widespread development. Some cases of OKC progress to the...
2.
Gotoh S, Ntege E, Nakasone T, Matayoshi A, Miyamoto S, Shimizu Y, et al.
Mol Clin Oncol
. 2022 Mar;
16(3):69.
PMID: 35251620
Mixed tumour of the skin or chondroid syringoma (CS) is a rare and mostly benign neoplasm of the sweat glands. Although CS is frequently located on varied parts of the...
3.
Makino W, Heianna J, Ishikawa K, Kusada T, Maemoto H, Ariga T, et al.
J Egypt Natl Canc Inst
. 2021 Dec;
33(1):40.
PMID: 34927227
Background: Postoperative chemoradiotherapy is recommended for patients with head and neck squamous cell carcinoma with positive margins or extracapsular extension at high risk of recurrence. However, high-dose radiotherapy in the...
4.
Gotoh S, Nakasone T, Matayoshi A, Makishi S, Hirano F, Ntege E, et al.
Mol Clin Oncol
. 2021 Dec;
16(1):7.
PMID: 34881027
Mucoepidermoid carcinomas (MECs) are rare head and neck malignant tumours that were originally considered to be benign. It has been estimated that ~20% of MECs in the major salivary glands,...
5.
Maruyama N, Umikawa M, Matsumoto H, Maruyama T, Nishihara K, Nakasone T, et al.
Anticancer Res
. 2020 Oct;
40(11):6101-6113.
PMID: 33109548
Background/aim: Oral squamous cell carcinoma (OSCC) is a common malignancy with poor prognosis. Therefore, novel therapeutic options are needed to improve prognosis of OSCC. Recently, microRNAs (miRs) have received increasing...
6.
Kato T, Matayoshi A, Nakasone T
Mol Clin Oncol
. 2020 Aug;
13(4):36.
PMID: 32802332
Aortic valve stenosis [or aortic stenosis, (AS)] is a risk factor in non-cardiac surgery. Guidelines from the European Heart Association recommended that AS treatment should be applied prior to non-cardiac...
7.
Maruyama N, Sasaki T, Arasaki A, Matsuzaki A, Nakasone T, Teruya T, et al.
Oncol Lett
. 2019 Aug;
18(3):2777-2788.
PMID: 31452756
The occurrence of second primary tumor (SPT)following malignancy treatment is common. In patients with head and neck (H&N) cancer, SPTs principally occur in the H&N region, lungs or esophagus. Therefore,...
8.
Maruyama N, Nakasone T, Arakaki O, Matsumoto H, Maruyama T, Matayoshi A, et al.
Oncol Lett
. 2018 Sep;
16(4):5249-5256.
PMID: 30250595
Second primary cancer (SPC) is an important prognostic factor for patients with head and neck cancer (HNC); therefore, the association between the prognosis and development of SPC has been well-reported....
9.
Maruyama N, Nishihara K, Nakasone T, Saio M, Maruyama T, Tedokon I, et al.
Oncol Lett
. 2018 Jun;
15(6):9901-9907.
PMID: 29928362
Second primary malignancy (SPM) is a severe issue for cancer survivors, particularly for osteosarcoma (OS) survivors. To date, the associations between subsequent SPM and OS have been well reported. Hematogenic...
10.
Nimura F, Nakasone T, Matsumoto H, Maruyama T, Matayoshi A, Maruyama N, et al.
Oncol Lett
. 2018 May;
15(5):7681-7688.
PMID: 29740489
Dedifferentiated liposarcoma (DDLS) has a relatively poor prognosis, however this neoplasm rarely occurs in the head and neck. To date, no definite protocol has been established for the diagnosis and...